药物性视神经病变

A. Horwitz, H. Horwitz
{"title":"药物性视神经病变","authors":"A. Horwitz, H. Horwitz","doi":"10.1097/FAD.0000000000000062","DOIUrl":null,"url":null,"abstract":"Summary Drug-induced optic neuropathy is an understudied subject, and most of the evidence is based on case-reports. Amiodarone, ciprofloxacin, disulfiram, and sildenafil have been associated with optic neuropathy and their use is relatively prevalent. We therefore set out to investigate the strength of this association. In this nationwide cohort, we identified all incident users of the four drugs studied during the period 1 January 1999 to 31 December 2018. We then investigated their incidence of optic neuropathy in the year prior to prescription and in the year following We found that the risk of being diagnosed with optic neuropathy was 2.27 [95% confidence interval (1.29–4.00)] higher times during amiodarone therapy than in the year prior to prescription, but for the three other drugs we found no certain association. This study revealed a weak association between optic neuropathy and amiodarone; however, we were unable to confirm any association with ciprofloxacin, sildenafil, and disulfiram.","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":"334 1","pages":"1295 - 1298"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Drug-induced optic neuropathy\",\"authors\":\"A. Horwitz, H. Horwitz\",\"doi\":\"10.1097/FAD.0000000000000062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Summary Drug-induced optic neuropathy is an understudied subject, and most of the evidence is based on case-reports. Amiodarone, ciprofloxacin, disulfiram, and sildenafil have been associated with optic neuropathy and their use is relatively prevalent. We therefore set out to investigate the strength of this association. In this nationwide cohort, we identified all incident users of the four drugs studied during the period 1 January 1999 to 31 December 2018. We then investigated their incidence of optic neuropathy in the year prior to prescription and in the year following We found that the risk of being diagnosed with optic neuropathy was 2.27 [95% confidence interval (1.29–4.00)] higher times during amiodarone therapy than in the year prior to prescription, but for the three other drugs we found no certain association. This study revealed a weak association between optic neuropathy and amiodarone; however, we were unable to confirm any association with ciprofloxacin, sildenafil, and disulfiram.\",\"PeriodicalId\":39261,\"journal\":{\"name\":\"Adverse Drug Reaction Bulletin\",\"volume\":\"334 1\",\"pages\":\"1295 - 1298\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Adverse Drug Reaction Bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/FAD.0000000000000062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Adverse Drug Reaction Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/FAD.0000000000000062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

药物性视神经病变是一个未被充分研究的课题,大多数证据都是基于病例报告。胺碘酮、环丙沙星、双硫仑和西地那非与视神经病变有关,它们的使用相对普遍。因此,我们着手调查这种关联的强度。在这个全国性队列中,我们确定了1999年1月1日至2018年12月31日期间所研究的四种药物的所有意外使用者。然后我们调查了他们在开药前一年和开药后一年视神经病变的发病率。我们发现,在胺碘酮治疗期间被诊断为视神经病变的风险为2.27[95%可信区间(1.29-4.00)],高于开药前一年,但对于其他三种药物,我们没有发现一定的关联。这项研究揭示了视神经病变与胺碘酮之间的微弱关联;然而,我们无法证实与环丙沙星、西地那非和双硫仑有任何关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Drug-induced optic neuropathy
Summary Drug-induced optic neuropathy is an understudied subject, and most of the evidence is based on case-reports. Amiodarone, ciprofloxacin, disulfiram, and sildenafil have been associated with optic neuropathy and their use is relatively prevalent. We therefore set out to investigate the strength of this association. In this nationwide cohort, we identified all incident users of the four drugs studied during the period 1 January 1999 to 31 December 2018. We then investigated their incidence of optic neuropathy in the year prior to prescription and in the year following We found that the risk of being diagnosed with optic neuropathy was 2.27 [95% confidence interval (1.29–4.00)] higher times during amiodarone therapy than in the year prior to prescription, but for the three other drugs we found no certain association. This study revealed a weak association between optic neuropathy and amiodarone; however, we were unable to confirm any association with ciprofloxacin, sildenafil, and disulfiram.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Adverse Drug Reaction Bulletin
Adverse Drug Reaction Bulletin Medicine-Pharmacology (medical)
CiteScore
0.70
自引率
0.00%
发文量
5
期刊介绍: For over 40 years, Adverse Drug Reaction Bulletin has provided comprehensive coverage in the field of adverse drug reactions. Each issue contains an invited article on a topic of current interest, dealing with specific conditions from drug-induced lung disorders to drug-induced sexual dysfunction, or types of drugs from lipid-lowering agents to poisons antidotes. This bimonthly journal"s articles are timely, succinct and fully referenced
期刊最新文献
A fatal outcome due to a continuous dosage of gentamicin: a case report A fatal outcome due to a continuous dosage of gentamicin: a case report Therapeutic outcomes arising from adverse drug reactions Subject and Drug Indexes to Adverse Drug Reaction Bulletin: Nos 338–343 February 2023 – December 2023 The evolution of pharmacovigilance: the contributions of Michael D Rawlins
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1